UC Conference and Event Services receives Champion Award

CES honored by Cincinnati USA Convention and Visitors Bureau

CES staff receiving award

UC Conference and Events Services (CES) staff received the Champion Award from the Cincinnati USA Convention and Visitors Bureau (CVB).

The CES staff received the award during the CVB's Annual meeting. CES Director Jamie Miller, Associate Director Katy Martson and Program Director Amber Lovett accepted the award for their work to bring the North American Manufacturing Conference to Cincinnati in 2020.

Each year the CVB honors individuals and organizations that have made significant contributions to convention and tourism success through the Spirit of Cincinnati USA Awards.  

CES was nominated for the award by Jeff Simic, CVB's national sales manager, because of strong partnership between CES and the CVB to help bring new, important and large groups to the Cincinnati region.  

Learn more about the CES partnership with the CVB and all that CES can do to help bring conferences to our city.

Conference and Event Services  certified event planners offer conference management, event planning, corporate event ideas and social event planning on campus, throughout Cincinnati or anywhere in the country. Visit the website for a full list of services.

 

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.